Insider Cluster (2 insiders) ·Filed Jul 9, 2026

ABEO

ABEONA THERAPEUTICS INC.
NEUTRAL
Impact 2/10
Horizondays Processed2mo ago
Insider cluster: 2 insiders, $172K total
Actionable Insight • Neutral

This insider selling cluster is too small to carry a directional signal. Both sales occurred on the same day at the same price, suggesting potentially coordinated or routine liquidity-driven dispositions. No follow-up monitoring needed unless larger non-10b5-1 sales emerge.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d
ABEO ▲ +3.72% at T+20d
NEUTRAL call ✓ call won +3.72% · α vs SPY +1.30% · entry $6.98 → $7.24
Next anchor: T+60d due 6h ago
Latest observation: T+58 -43.13% FF3 residual α
Entry anchored
Jul 9, 03:59 PM ET
via exchange tick
T+1d
+0.43%
call +0.43% · α +1.20%
$7.01
settled 3mo ago
T+5d
+0.57%
call +0.57% · α +1.13%
$7.02
settled 3mo ago
T+20d
+3.72%
call +3.72% · α +1.30%
$7.24
settled 8w ago
T+60d
—
call — · α —
—
due 6h ago

Price Chart

Loading chart...

Executive Summary

Two insiders at Abeona Therapeutics (ABEO) — the Chief Commercial Officer and SVP/Chief Legal Officer — conducted open-market sales totaling approximately $172K on July 9, 2026. The combined value represents less than 0.05% of the company's $388M market cap, making the cluster economically trivial and consistent with routine portfolio management rather than a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$172.0K
Insiders
2

Key Facts

  • Two insiders sold shares on 2026-07-09: CCO Madhav Vasanthavada (12,606 shares, ~$88K) and SVP/CLO Brendan M. O'Malley (12,050 shares, ~$84K)
  • Total proceeds: approximately $172K
  • Combined sales represent ~0.044% of ABEO's $388M market capitalization
  • No open-market purchases were reported in the same window

Financial Impact

Insignificant relative to market cap — total sales under $200K

no material impact on financial metrics

Risk Factors

  • If insiders accelerate selling in future clusters without a 10b5-1 plan, that could signal growing bearish conviction
  • ABEO's small market cap means even modest insider selling can appear proportionally larger — but this cluster remains within noise levels

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ABEO-1783639232065
19 reports for ABEO
Performance horizon
33% Hit rate 1 of 3 directional calls best @ T+1▲ +3.70%Aug 14, 2026
Filters
Rows
Reports for ABEO — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
8-K
NEUTRAL ★ 2/10
$5.47 $5.57▲ +1.83%▲ +1.01%$5.03 (−8.14%)
Aug 14, 2026
6w ago
Institutional Cluster
BULLISH ★ 5/10
$5.94 $6.06▲ +2.02%▲ +3.21%$5.03 (−15.40%)
Aug 13, 2026
7w ago
8-K
NEUTRAL ★ 5/10
$6.35 $5.96▼ −6.07%▼ −4.10%$5.03 (−20.80%)
Aug 13, 2026
7w ago
Press Release
MIXED ★ 6/10
$6.35 $5.96▼ −6.07%▼ −4.10%$5.03 (−20.80%)
Jul 9, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$6.98 $7.02▲ +0.57%▲ +1.13%$5.03 (−28.01%)
Jun 15, 2026
15w ago
Insider Cluster
NEUTRAL ★ 4/10
$5.65 $5.72▲ +1.24%▲ +3.47%$5.03 (−11.06%)
Jun 15, 2026
15w ago
Insider Cluster
BEARISH ★ 5/10
$5.65 $5.72▼ −1.24%▼ −3.47%$5.03 (+11.06%)
Jun 12, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$5.53 $5.77▲ +4.34%▲ +3.67%$5.03 (−9.13%)
Jun 10, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$5.53 $5.65▲ +2.17%▲ +1.74%$5.03 (−9.13%)
Jun 10, 2026
16w ago
Insider Cluster
BEARISH ★ 5/10
$5.36 $5.65▼ −5.41%▼ −1.98%$5.03 (+6.25%)
Showing 10 of 19

US Market Status

Market Open — Closes in 2h 17m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 9, 2026